跳至主要内容
临床试验/NCT02894671
NCT02894671已完成不适用

Ischemia Modified Albumin (IMA) Expression in the Male and Female Population

Istituto Ortopedico Rizzoli1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
IMA dosage

研究概览

简要总结

The study has as general objective to analyze in the adult population, (male and female) the presence of a very common protein, in its normal form and modified, isolated from the blood of patients and called albumin. The opportunity to observe the distribution of this protein in the population, provides the basis to be able to perform this type of assay also in the population of patients with pathologies, in the near future, with the aim of increasing knowledge on the subjective tolerability to orthopedic implants.

详细描述

100 patients, waiting for elective surgical intervention (such as hip replacement or primary knee ligament reconstruction, arthroscopy), distributed evenly by gender and age (50 men, 50 women including 25 postmenopausal and 25 in bearing age) and afferent to the Department of Surgery Prosthetic hip and knee of our Institute, will be enrolled. At execution time of blood sampling routine, a further specimen of whole blood (7 ml) will be added which will be sent to the Medical technology laboratory for IMA dosage. In addition, total albumin, ferritin, transferrin and serum iron will be analyzed from clinical pathological laboratory. The investigators will be able to analyze the IMA and normalized IMA distributions with respect to gender factor and correlation with the three listed blood tests (ferritin, transferrin and serum iron).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • signed informative consensus

排除标准

  • patients wearing articular devices
  • pregnant (for female)
  • fractured patients
  • patients with oncologic diseases, hemochromatosis, hepatic diseases, thalassaemia, diabetes, anemia (Hb<9)

结局指标

主要结局

IMA dosage

时间窗: one year

Dosage of IMA (mg/ml), with ELISA assay for each patient

次要结局

  • iron, transferrin dosages(one year)
  • Ferritin dosages(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giovanni Bracci

MD

Istituto Ortopedico Rizzoli

研究点 (1)

Loading locations...

相似试验